Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

Surviving later-stage lung or colon cancer comes about as a result of a combination of healthy eating, remaining as active as ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person ...

I finally felt like a survivor the day I heard my 18-month scans were clear, shifting from fear to faith and realizing I was ...

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.

I was diagnosed with follicular lymphoma in 2020, during COVID, which forced me to retire early and taught me I’m more than a ...

A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life ...

Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a ...

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, ...